Charles Hugh-Jones
Amministratore Delegato presso Volastra Therapeutics, Inc.
Posizioni attive di Charles Hugh-Jones
Società | Posizione | Inizio | Fine |
---|---|---|---|
Volastra Therapeutics, Inc.
Volastra Therapeutics, Inc. BiotechnologyHealth Technology Volastra Therapeutics, Inc. develops novel therapies for patients with metastatic cancers. The company was founded by Lewis Cantley, Samuel Bakhoum and Olivier Elemento and is headquartered in Boston, MA. | Amministratore Delegato | - | - |
Storia della carriera di Charles Hugh-Jones
Precedenti posizioni note di Charles Hugh-Jones
Società | Posizione | Inizio | Fine |
---|---|---|---|
ALLERGAN PLC | Direttore Tecnico/Scientifico/R&S | 14/08/2018 | 08/05/2020 |
Statistiche
Distribuzione geografica
Stati Uniti | 3 |
Posizioni
Chief Tech/Sci/R&D Officer | 1 |
Chief Executive Officer | 1 |
Settori
Health Technology | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 2 |
---|---|
Allergan Ltd. (Ireland)
Allergan Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1982 and is headquartered in Dublin, Ireland. | Health Technology |
Volastra Therapeutics, Inc.
Volastra Therapeutics, Inc. BiotechnologyHealth Technology Volastra Therapeutics, Inc. develops novel therapies for patients with metastatic cancers. The company was founded by Lewis Cantley, Samuel Bakhoum and Olivier Elemento and is headquartered in Boston, MA. | Health Technology |
- Borsa valori
- Insiders
- Charles Hugh-Jones
- Esperienza